Oral Semaglutide Shows Promise for Pediatric Type 2 Diabetes Management
A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes
Background
Type 2 Diabetes is an escalating health concern in children and adolescents, leading to severe long-term complications. While effective injectable treatments exist for adults, there's a significant lack of convenient and effective oral treatment options specifically tailored for this younger population. This Phase 3 study investigates the efficacy and safety of an oral form of semaglutide to address this critical unmet need.
TitrateLab articles covering Semaglutide
Written by TitrateLab, separately from the study summarized above.
